trial · primary record
Brachytherapy
Prostate Cancer
| Phase | Phase 1 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 42 |
| Primary completion | 2040-01-01 |
| Primary endpoint | Dose limiting toxicities (DLT) graded according to the National Cancer Institute, Common Toxicity Criteria (NCI, CTC), v 4.0 |
| Registry ID | NCT01655836 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:41:20.957Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT01655836
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.